Amir Blatt

Venture Investments, Johnson & Johnson | Founding Partner, Almeda Ventures

📍 Israel, Israel🔄 Updated September 2026💼 8 investments📅 13 years investing🗓 Last invested Jan 2025
VC🌍 Israel
8
Total investments
3
Early stage
1
Mid stage
2
Late stage
13y
Years active

Portfolio

7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Venture Investor, JJDC
2025
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines
Board Observer
2021
Augmedics pioneers cutting-edge augmented reality technologies to improve surgical outcomes. The company’s revolutionary xvision Spine System® allows surgeons to see patients’ anatomy as if they have “x-ray vision” and accurately navigate instruments and implants during spine procedures. The first-of-its-kind, FDA-cleared xvision has been used to treat over 8,500 patients and implant more than 45,000 pedicle screws across 25 US states. Augmedics has received numerous honors, including being named a 2021 Index Awards Finalist, a Fast Company World Changing Ideas Awards 2021 Finalist, and one of Time Magazine’s Best Inventions of 2020. To learn more or schedule an xvision demo, visit augmedics.com.
Board Member
2019
We imagine a world where the most advanced technologies in the field of artificial intelligence are harnessed to make healthcare better, affordable, and more widely available. Our amazing human-machine hybrid AI diagnostic system allows us to build powerful predictive analytics models that solve a worldwide challenge – strained health budgets and workforces.
Board Member
2019
TailorMed offers the nation’s largest network of patients, providers, pharmacies, partners, and life science companies focused on ensuring all patients across all medical conditions can afford treatment. Driven by TailorMed's best-in-class platform, network constituents can proactively identify, match, and enroll patients in financial assistance programs to deliver a world-class patient financial experience while reducing the cost of care delivery and increasing revenues. TailorMed’s secure, web-based financial assistance solutions are deployed across more than 1,000 sites of care, including Providence Health, UnityPoint Health, Yale-New Haven Health, and Advocate Aurora Health.
Board Member
2017
CartiHeal, a privately-held medical device company with headquarters in Israel, develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints. CartiHeal’s cell-free, off-the-shelf implant is CE marked for use in cartilage and osteochondral defects. Agili-C has been implanted in over 400 patients with cartilage lesions in the knee, ankle and great toe in a series of trials conducted in leading centers in Europe and Israel. In these trials, the implant was used to treat a broad spectrum of cartilage lesions, from single focal lesions to multiple and large defects in patients suffering from osteoarthritis. In the United States the Agili-C implant is not available for sale - it is an investigational device limited for use in the IDE study.
Board Member
2013
Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation. Its product line includes solutions for the repair and replacement of the mitral valve as well as the repair of the tricuspid valve. Our breakthrough mitral valve treatment platform is based on a D-shaped ring which serves both as a docking station for Valcare’s unique replacement prosthesis, and as a highly-effective tool for mitral annulus repair. Our mitral repair and replacement systems as well as our tricuspid repair solution establish Valcare Medical as a leader in valve care, a responsibility we very much take to heart.
Board Member
2013
Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation. Its product line includes solutions for the repair and replacement of the mitral valve as well as the repair of the tricuspid valve. Our breakthrough mitral valve treatment platform is based on a D-shaped ring which serves both as a docking station for Valcare’s unique replacement prosthesis, and as a highly-effective tool for mitral annulus repair. Our mitral repair and replacement systems as well as our tricuspid repair solution establish Valcare Medical as a leader in valve care, a responsibility we very much take to heart.
Experience · 12 entries
All (12)
Investments (8)
Board (7)
2025
Venture Investor, JJDC
2025
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines
2021
Board Observer
2021
Augmedics pioneers cutting-edge augmented reality technologies to improve surgical outcomes. The company’s revolutionary xvision Spine System® allows surgeons to see patients’ anatomy as if they have “x-ray vision” and accurately navigate instruments and implants during spine procedures. The first-of-its-kind, FDA-cleared xvision has been used to treat over 8,500 patients and implant more than 45,000 pedicle screws across 25 US states. Augmedics has received numerous honors, including being named a 2021 Index Awards Finalist, a Fast Company World Changing Ideas Awards 2021 Finalist, and one of Time Magazine’s Best Inventions of 2020. To learn more or schedule an xvision demo, visit augmedics.com.
2020
Founding Partner & CIO
2020
Almeda Ventures - The Next Generation of HealthTech Investments Investing in Medical Device, Digital Health and Bio-Convergence
2019
Board Member
2019
We imagine a world where the most advanced technologies in the field of artificial intelligence are harnessed to make healthcare better, affordable, and more widely available. Our amazing human-machine hybrid AI diagnostic system allows us to build powerful predictive analytics models that solve a worldwide challenge – strained health budgets and workforces.
Board Member
2019
TailorMed offers the nation’s largest network of patients, providers, pharmacies, partners, and life science companies focused on ensuring all patients across all medical conditions can afford treatment. Driven by TailorMed's best-in-class platform, network constituents can proactively identify, match, and enroll patients in financial assistance programs to deliver a world-class patient financial experience while reducing the cost of care delivery and increasing revenues. TailorMed’s secure, web-based financial assistance solutions are deployed across more than 1,000 sites of care, including Providence Health, UnityPoint Health, Yale-New Haven Health, and Advocate Aurora Health.
Show all 12 entries ↓
Investment activity
2013–2025 · 8 investments
201322017120181201922021120251
Recent (last 2 years)Earlier